This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

US backs waiver on patents for Covid-19 vaccines

The US government has declared its support for a temporary suspension of intellectual property rights for Covid-19 vaccines.

The waiver, previously called for by India and South Africa, but opposed by the EU Commission and UK government, is yet to be approved at the WTO.

The US has declared its support for a patent waiver on Covid-19 vaccines to boost their production and distribution around the world.


life sciences, life sciences regulatory, patent litigation, covid